[Malignant hypercalcemia during Basedow's disease].
D000236:Adenoma / Q000150:complications; D000328:Adult; D001714:Bipolar Disorder / Q000209:etiology; D001862:Bone Resorption; D002116:Calcitonin / Q000172:deficiency; D002118:Calcium / Q000097:blood; D002231:Carbimazole / Q000627:therapeutic use; D006111:Graves Disease / Q000150:complications*; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D006934:Hypercalcemia / Q000209:etiology* / Q000503:physiopathology; D006980:Hyperthyroidism / Q000150:complications; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008297:Male; D010281:Parathyroid Hormone / Q000502:physiology; D010282:Parathyroid Neoplasms / Q000150:complications; D010758:Phosphorus / Q000008:administration & dosage / Q000097:blood; D013963:Thyroid Hormones / Q000502:physiology; D014807:Vitamin D / Q000502:physiology; D014839:Vomiting / Q000209:etiology
D007457:Iodine Radioisotopes; D010281:Parathyroid Hormone; D013963:Thyroid Hormones; D014807:Vitamin D; D010758:Phosphorus; D002231:Carbimazole; D002116:Calcitonin; D006909:Hydroxyproline; D002118:Calcium
Hypercalcémie maligne au cours d'une maladie de Basedow